2023
DOI: 10.1016/j.phymed.2023.154734
|View full text |Cite
|
Sign up to set email alerts
|

Effects of luteolin on sepsis: A comprehensive systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 93 publications
0
5
0
Order By: Relevance
“…Previous studies reported that both luteolin and kaempferol downregulate MAPK/NF-κB-mediated inflammation [ 36 , 37 ]. Luteolin has been reported to attenuate LPS-induced organ damage and myocardial injury [ 38 , 39 ]. In addition, kaempferol has been reported to potentially inhibit oxidative tissue injury and pulmonary inflammatory response [ 40 ].…”
Section: Resultsmentioning
confidence: 99%
“…Previous studies reported that both luteolin and kaempferol downregulate MAPK/NF-κB-mediated inflammation [ 36 , 37 ]. Luteolin has been reported to attenuate LPS-induced organ damage and myocardial injury [ 38 , 39 ]. In addition, kaempferol has been reported to potentially inhibit oxidative tissue injury and pulmonary inflammatory response [ 40 ].…”
Section: Resultsmentioning
confidence: 99%
“…[13] It has a benefi cial eff ect on sepsis through multiple pathways, such as alleviating oxidative stress, infl uencing the initiation of inflammatory pathways, reducing the expression of inflammatory factors, and modulating the immune response. [14] Kaempferol is a natural polyphenol small molecule that can inhibit oxidative stress injury and inflammation in the livers of septic rats. [15] Kaempferol can combat sepsis by alleviating the inflammatory response induced by lipopolysaccharides through the regulation of the sphingosine kinase type 1/sphingosine 1-phosphate (SphK1/S1P) signaling pathway, thus stabilizing the endothelial barrier.…”
Section: Discussionmentioning
confidence: 99%
“…[34] More and more studies have shown that luteolin can be used to treat gouty arthritis, diabetes, tumors, and cardiovascular and cerebrovascular diseases. [35][36][37][38][39] Researchers found that luteolin can reduce joint synovial hyperplasia, cartilage, and bone erosion in GA rats. [40] Luteolin reduces the expression of MyD88 by regulating TLR4 receptors, thereby inhibiting the expression of NF-κB-related proteins, reducing the release of related inflammatory factors, and alleviating the inflammatory cascade, thereby protecting joints.…”
Section: Luteolinmentioning
confidence: 99%